Sidley Austin LLP advised Vivo Capital and Novo Holdings A/S as lead investors on the deal, while Davis Polk advised Esco Lifesciences. Vivo Capital and Novo…
Esco Lifesciences’ US$200 Million Series A Financing


Sidley Austin LLP advised Vivo Capital and Novo Holdings A/S as lead investors on the deal, while Davis Polk advised Esco Lifesciences. Vivo Capital and Novo…
…